Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 22Gastrointestinal 16Gynecologic 5Head & Neck 4Tumor-Agnostic 3Thoracic 3Other hematologic neoplasm 2Genitourinary 2Endocrine 2Other solid neoplasm 1Other 1Lymphoid 1CNS 1

Conditions

Pheochromocytoma 1Multiple Endocrine Neoplasia Type 1 1Depression 1

Interventions

Everolimus 32Octreotide 15Cisplatin 14pasireotide 13Sunitinib 13Temozolomide 11pembrolizumab 10Etoposide 10Doxorubicin 10lanreotide 9Magnetic Resonance Spectroscopy 9Bevacizumab 9lutetium Lu 177 dotatate 8gallium Ga 68 dotatate 8Sorafenib 8Paclitaxel 83-Iodobenzylguanidine 8lenvatinib 7pazopanib 6Radiotherapy 6Positron Emission Tomography Computed Tomography 6surufatinib 5cabozantinib 5avelumab 5Thyrotropin Alfa 5Surgical Procedures, Operative 5Radiosurgery 5Nivolumab 5Mitotane 5Irinotecan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Control Groups × Endocrine × Clear all
NCT04320589 2021-09-01

the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma

National Cancer Institute, Egypt

Phase 2 Completed
30 enrolled
Endocrine

Pheochromocytoma

NCT02777112 2019-05-17

The Effects of E-mental Health Program and Job Coaching on the Risk of Major Depression in Canadian Working Men

University of Calgary

Phase NA Completed
1,133 enrolled
Endocrine

Depression, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡